Presidential Contenders Sharpen Their Focus On Scientific Issues As Election Approach

Although Clinton and Bush disagree on the details, both candidates support increased efforts in R&D As the United States presidential campaign heads into its final stages, President George Bush and Democratic challenger Gov. Bill Clinton are maneuvering for the political high ground on the subject of high tech--particularly technology-driv-en approaches to bolstering the nation's economy and global competitiveness. Both candidates occasionally have addressed issues of federal support for bas

Written byBarton Reppert
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Both candidates occasionally have addressed issues of federal support for basic science in speeches and position papers. But they have been devoting considerably more effort to articulating the economic and environmental benefits to be reaped from applied research, new technologies, and revitalized U.S. research and development facilities.

Despite their enthusiasm for high tech, however, Bush and Clinton pointedly disagree about how the government should go about encouraging the growth of private-sector R&D investment and technology-based industries.

Considerably less divergent than their positions concerning R&D and technology development have been the candidates' views on basic science. While neither has been particularly vocal on the subject, both have expressed support for sustaining U.S. strength in basic research.

Clinton, for example, has stated in a position paper that "university research accounts for a large part of the federal basic research budget. Funding for basic university research should continue to be provided for a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies